Tricuspid stenosis overview

Tricuspid stenosis Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Tricuspid stenosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Tricuspid stenosis overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tricuspid stenosis overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tricuspid stenosis overview
CDC on Tricuspid stenosis overview
Tricuspid stenosis overview in the news
Blogs on Tricuspid stenosis overview
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Tricuspid stenosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief:

Overview

Tricuspid stenosis (TS) is a type of valvular heart disease where there is narrowing of the orifice of the tricuspid valve of the heart. A majority of stenotic tricuspid valves are associated with evidence of tricuspid regurgitation. Tricuspid stenosis is quite uncommon in developed countries due to the low prevalence of rheumatic heart disease, which is the commonest cause of TS. It is the least common valvular stenosis lesion, and generally accompanies mitral and/or aortic valve involvement. It is extremely rare to have isolated acquired tricuspid stenosis. Rheumatic tricuspid valve disease seldom receives much attention and can be easily overlooked on routine clinical and echocardiographic examination, which may lead to postoperative problems after successfully relieving left-sided valvular disease. The clinical findings associated with rheumatic mitral valve disease are also more severe than that of rheumatic tricuspid valve disease, making it rather easy to miss the diagnosis of concomitant tricuspid stenosis (TS). There is a paucity of literature on the prevalence and management of rheumatic tricuspid valve disease. Most of the literature on rheumatic tricuspid stenosis are old, which may be reflective of the low prevalence of rheumatic heart disease in developed countries. However, developing countries and the Indian subcontinent still have a significant prevalence of rheumatic tricuspid valve disease, occurring mostly in young women. Stenotic tricuspid valves are usually anatomically abnormal, and often take years to develop, with few exceptions such as congenital causes, active endocarditis.

Classification

Tricuspid stenosis is staged based on the valve anatomy and hemodynamics, and the hemodynamic consequences.

Stage Definition Valve anatomy Valve hemodynamics Hemodynamic consequences Symptoms C, D Severe TS Thickened, distorted, calcified leaflets T ½ ≥190 ms  Valve area ≤1.0 cm2 Right atrial / Inferior vena cava enlargement Stage C-No symptoms Stage D-Symptoms variable and dependent on the severity of associated valve disease and degree of obstruction

Pathophysiology

TS is characterized by structural changes in the tricuspid valve. The pathophysiology of tricuspid valve stenosis depends on the underlying etiology. In rheumatic heart disease which is the most common cause of TS, there is diffuse scarring and fibrosis of the valve leaflets, fusion of the commissures, and shortening of the chordae tendineae as a result of inflammation. These abnormalities limit leaflet mobility and reduce the size of the tricuspid orifice, increasing the transtricuspid diastolic gradient, which can eventually result in systemic venous hypertension and congestion.

The pathophysiology of tricuspid stenosis based on the underlying etiology:

Rheumatic tricuspid stenosis: Diffuse scarring and fibrosis of the valve leaflets from inflammation. Fusion of the commissures may or may not occur. Chordae tendineae may become thickened and shortened. As a result of the dense collagen and elastic fibers that make up leaflet tissue, the normal leaflet layers become significantly distorted. Carcinoid heart disease: Fibrous white plaques located on the valvular and mural endocardium are characteristic presentations of carcinoid valve lesions. Valve leaflets become thick, rigid and smaller in area. Atrial and ventricular surfaces of the valve structure contain fibrous tissue proliferation. Congenital tricuspid stenosis: More common in infants Lesions may present in a number of different ways, either singularly or in any combination of the following: Incompletely developed leaflets Shortened or malformed chordae Small annuli Papillary muscles of abnormal size and number Mechanical obstruction of flow through the tricuspid valve: Supravalvular obstruction from congenital diaphragms Intracardiac or extracardiac tumors Thrombosis or emboli Large endocarditis vegetations Causes

The most common cause of TS is rheumatic heart disease. Other causes of TS include carcinoid syndrome, congenital abnormalities, endocarditis, lupus, and mechanical obstruction by a tumor.

Common Causes Rheumatic heart disease (majority of the cases) Carcinoid syndrome Congenital

Etiology of tricuspid stenosis in operatively excised valves in patients >15years

Etiology of tricuspid stenosis in 97 operatively excised stenotic tricuspid valves Rheumatic Carcinoid Congenital Ebstein's anomaly Complex heart disease Shortened chordae and/or fused commissure 90 3 1 2 1 Causes by Organ System Cardiovascular Congenital heart disease, cardiac tumor, saphenous vein bypass graft aneurysm, Ebstein's anomaly, endomyocardial fibrosis, infective endocarditis, myxoma, thrombus, rheumatic heart disease Chemical/Poisoning No underlying causes Dental No underlying causes Dermatologic No underlying causes Drug Side Effect Methysergide Ear Nose Throat No underlying causes Endocrine Carcinoid syndrome Environmental No underlying causes Gastroenterologic No underlying causes Genetic No underlying causes Hematologic No underlying causes Iatrogenic Pacemaker infection, pacemaker leads, device closure of right coronary arteriovenous fistula. Infectious Disease Infective endocarditis Musculoskeletal/Orthopedic No underlying causes Neurologic No underlying causes Nutritional/Metabolic Fabry disease, Whipple's disease Obstetric/Gynecologic No underlying causes Oncologic Carcinoid syndrome, cardiac tumor, intravenous leiomyomatous tumor, metastatic tumor, myxoma Ophthalmologic No underlying causes Overdose/Toxicity No underlying causes Psychiatric No underlying causes Pulmonary No underlying causes Renal/Electrolyte No underlying causes Rheumatology/Immunology/Allergy Amyloidosis, systemic lupus erythematosus Sexual No underlying causes Trauma No underlying causes Urologic No underlying causes Miscellaneous Giant blood cyst Causes by Alphabetical Order Amyloidosis Carcinoid syndrome Cardiac tumor/Thrombus Congenital heart disease Ebstein's anomaly Endomyocardial fibrosis Fabry disease Giant blood cyst Infective endocarditis Intravenous leiomyomatous tumor Metastatic tumor Myxoma Pacemaker infection Pacemaker leads Rheumatic heart disease Systemic lupus erythematosus Whipple's disease Differential Diagnosis

The differential diagnosis of tricuspid stenosis include valvular abnormalities causing a similar clinical presentation, and other causes of systemic venous congestion. The heart murmur of tricuspid stenosis must be differentiated from that of other valvular diseases. However, it should be noted that tricuspid stenosis often co-exist with other valvular pathologies such as tricuspid regurgitation, mitral valve and aortic valve abnormalities. Tricuspid stenosis is characterized by a mid diastolic murmur best heard over the left sternal border. It has a rumbling character, a tricuspid opening snap with wide splitting of S1. The differential diagnosis of tricuspid stenosis includes:

Aortic regurgitation: The diastolic murmur of aortic regurgitation decreases with respiration, which is in contrast to that of tricuspid stenosis. Mitral regurgitation: The murmur of mitral regurgitation is blowing, soft and best heard at the apex. Mitral stenosis: The murmur of mitral stenosis is mid-diastolic, rumbling, and best heard after the opening snap. Tricuspid regurgitation: The murmur of tricuspid regurgitation is blowing, holosystolic, and best heard over the fourth intercostal area at the left sternal border.

Tricuspid stenosis should also be differentiated from diseases causing a similar clinical presentation,such as:

Tricuspid atresia Constrictive pericarditis Restrictive cardiomyopathy Atrial myxoma Epidemiology and Demographics

TS is the least common valvular disease. TS is rarely an isolated disease, it is mostly associated with mitral and/or aortic valve abnormalities with/without concomitant tricuspid regurgitation.

Prevalence

A prospective study of the echocardiographic profile of tricuspid valve disease in 788 patients with rheumatic heart disease in India was done. 9% of the patients had tricuspid valve disease and half of these patients with tricuspid valve disease had tricuspid stenosis with/without tricuspid regurgitation. The prevalence of TS is lower in developed countries compared to the developing countries due to the low prevalence of rheumatic heart disease.

Gender

Most patients with rheumatic tricuspid stenosis are young women with mitral and/or aortic valve disease.

Risk Factors

One of the most recognized risk factors for TS is rheumatic fever.

Natural History, Complications, and Prognosis Natural history

The natural course of tricuspid stenosis is not well defined. It is extremely rare for TS to occur in isolation, it is usually associated with existing mitral valve disease with/without concomitant tricuspid regurgitation. The most common cause of TS is rheumatic heart disease and it is usually associated with coexisting mitral valve and/or aortic valve abnormality. TS of rheumatic etiology usually occurs with tricuspid regurgitation. Tricuspid stenosis often takes years to develop ,with some exceptions such as congenital causes and active infective endocarditis. Complications of tricuspid stenosis include heart failure, liver failure, and stroke.

Complications of TS Right atrial enlargement Atrial fibrillation Heart failure Infective endocarditis Cerebrovascular accident Liver failure Prognosis

With medical intervention, severe tricuspid stenosis appears well tolerated over several years of follow-up.

Diagnosis History and Symptoms

Tricuspid stenosis is mostly associated with mitral valve abnormalities. Common symptoms include dyspnea, peripheral edema, and fatigue.

Signs and Symptoms Fatigue Dyspnea Abdominal discomfort (due to hepatomegaly secondary to systemic venous congestion) Pedal edema Jugular venous distension Heart murmur Physical Examination

Tricuspid stenosis often co-exists with mitral stenosis, thus depending on the severity of mitral valve pathology, symptoms differ. The diagnosis of TS may also be missed when they coexist. Patients can lay flat without any symptoms in the absence of serious mitral valve pathology and thus, not present with any signs of dyspnea. Characteristic findings of TS include an opening snap and a low to medium pitch diastolic rumbling murmur, usually localized to the lower left sternal border (fourth intercostal space) with inspiratory accentuation.

Echocardiogram

Transthoracic echocardiography (TTE) should be performed among patients with suspected TS to confirm the diagnosis, determine the etiology, and establish the baseline severity. TTE commonly reveals findings associated with other valvular diseases, such as tricuspid regurgitation and/or mitral stenosis. TS is mainly characterized by an elevated transvalvular gradient. TTE helps in the determination of the anatomic and hemodynamic characteristics of the tricuspid valve. TTE allows the detection of the following:

Tricuspid valve thickening and calcification Chordal thickening and calcification Decreased valve mobility with diastolic doming Reduced leaflet separation at peak opening Immobility of the leaflets ('frozen' appearance seen in carcinoid syndrome) Atrial tumors or metastatic lesions Valvular vegetations (suggestive of infective endocarditis) Right atrial ball valve thrombus

Doppler echocardiography: The evaluation of the severity of tricuspid stenosis is primarily done using the haemodynamic information provided by continuous wave Doppler (CWD). Doppler echocardiography is useful to assess the severity of TS through the evaluation of the transvalvular gradient (the hallmark of a stenotic valve is an increase in transvalvular velocity recorded by CWD). The assessment of the tricuspid valve area is limited by the common association of TS with tricuspid regurgitation. The coexistence of tricuspid regurgitation causes the underestimation of the tricuspid valvular area. A tricuspid valve area < 1.0 cm2 is associated with increased severity of the TS.

Findings Associated with Increased Severity

TTE findings that are associated with increased severity of tricuspid stenosis include:

Mean pressure gradient >5 mm Hg, Pressure half-time >190 milliseconds Tricuspid valve area < 1.0 cm2 Enlargement of the right atrium Dilation of the inferior vena cava 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary Class I "1. TTE is indicated in patients with TS to assess the anatomy of the valve complex, evaluate severity of stenosis, and characterize any associated regurgitation and/or left-sided valve disease. (Level of Evidence: C)"

Electrocardiogram

The electrocardiogram of patients with TS can demonstrate a sinus rhythm with or without right atrial hypertrophy. Patients with TS experience frequent arrhythmias, particularly atrial flutter and/or atrial fibrillation due to the enlargement of the right atrium. EKG findings suggestive of coexisting mitral valve disease can also be seen.

Chest X ray

The chest X-ray in a patient with tricuspid stenosis may show right atrial enlargement. The heart size can range from a normal-sized heart to cardiomegaly, with additional findings suggestive of coexisting valvular pathology such as mitral stenosis.

Cardiac MRI

While echocardiography remains the diagnostic imaging modality of choice, cardiac MRI is useful to evaluate tricuspid stenosis when the results of the echocardiography are insufficient.

ACC/AHA Guidelines- ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance (DO NOT EDIT) “

CMR may be used for assessing individuals with valvular heart disease in which evaluation of valvular stenosis, regurgitation, para- or perivalvular masses, perivalvular complications of infectious processes, or prosthetic valve disease are needed. CMR may be useful in identifying serial changes in LV volumes or mass in patients with valvular dysfunction.

”

Cardiac Catheterization

While echocardiography remains the diagnostic imaging modality of choice, cardiac catheterization is useful to evaluate tricuspid stenosis when the results of the non-invasive testing are insufficient, particularly among patients who are being evaluated for other conditions such as mitral stenosis and pulmonary hypertension. In the older pre-surgery population, cardiac catheterization may be necessary in order to assess concomitant artery disease.

Catheterization of the right heart is useful for the evaluation of:

The gradient across the tricuspid valve Associated congenital defects

Catheterization of the left heart is useful for the assessment of hemodynamic changes related to the aortic and mitral valves in patients with rheumatic heart disease.

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary Class IIb "1. Invasive hemodynamic assessment of severity of TS may be considered in symptomatic patients when clinical and noninvasive data are discordant. (Level of Evidence: C)"

Treatment Medical Therapy

Medical therapy with diuretics and sodium restriction for patients with TS with systemic venous congestion. Patients with TS should receive medical therapy for left heart failure, and/or pulmonary hypertension if they are present. Treatment of the underlying etiology and associated conditions/complications is necessary. Fibrinolytic therapy is the first line therapy for prosthetic tricuspid valve thrombosis resulting in tricuspid stenosis.

Surgery

Tricuspid valve surgery is recommended for patients undergoing surgical intervention for left valvular disease as well as among patients with severe symptomatic isolated TS. Tricuspid valve balloon valvuloplasty has a limited efficacy in the management of tricuspid stenosis.